Melanotan II's Brain Target for Thermogenic and Metabolic Effects Identified in Rats

The melanocortin system, a complex network of peptides and receptors in the brain, plays a critical role in regulating energy balance, appetite, and body temperature. Melanotan II (MT-II) is a synthetic peptide that acts as a potent melanocortin receptor agonist, known to induce thermogenesis (heat production) and reduce food intake. However, the precise brain regions mediating these specific thermogenic and metabolic actions of MT-II have not been fully elucidated, particularly regarding its direct effects on temperature regulation centers.

The study revealed that direct administration of Melanotan II into the medial preoptic nucleus significantly impacted both thermogenic and metabolic parameters. Within 2 hours of injection, treated rats exhibited a robust increase in core body temperature. The most important finding was a sustained elevation of core body temperature by 1.8 ± 0.2°C compared to vehicle controls (p<0.001), peaking at 4 hours post-injection and remaining elevated for 8 hours. Furthermore, oxygen consumption, indicative of energy expenditure, showed a significant 32% increase over the 6-hour post-injection period (p<0.001). Concurrently, food intake was markedly suppressed, with a 45% reduction observed over the 24-hour monitoring period in the MT-II group compared to controls (p<0.001), demonstrating a potent anorexigenic effect mediated by this specific brain region.